Compare Humana Inc (HUM) vs Kinross Gold Corporation (KGC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Kinross Gold Corporation — how do they compare? Humana Inc trades at $374.25 (market cap $46.31B), while Kinross Gold Corporation trades at $27.59 (market cap $32.46B). The key difference: Humana Inc is the larger of the two by market cap, and Humana Inc pays the higher dividend (0.92%). Which is the better fit depends on your goals.
| HUM | KGC | |
|---|---|---|
Market Cap | $46.31B | $32.46B |
Sector | Health | Basic Materials |
52-Week High | $409.42 | $38.06 |
52-Week Low | $163.67 | $18.70 |
Enterprise Value | $53.67B | $30.54B |
Dividend Yield | 0.92% | 0.58% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $385.00, up 4.82% today, with a bullish technical outlook and analyst consensus price target of $399.53. Recent earnings beats in Q1 and Q2 2026, alongside revenue growth to $129.66 billion in 2025, support fundamentals, though net margins have compressed. The company is expanding its Medicaid business and targeting margin improvements by 2027.
The stock offers upside to consensus targets but faces risks from Medicare Advantage margin pressures and regulatory changes. Profitability trends are weak despite revenue growth, requiring successful cost management to meet 2028 targets. Institutional sentiment is mixed with a majority hold rating.
Kinross Gold (KGC) trades at $27.64, up 7.88% with strong momentum following recent earnings beats. The stock shows bullish technical signals with robust fundamentals including 37.52% net margins and 36.95% ROE. Recent S&P credit upgrade to 'BBB' and consistent dividend payments support positive sentiment. Valuation remains attractive with P/E of 10.51 and EV/EBITDA of 5.48.
Outlook remains positive with projected revenue growth to $8.5B in 2026 and strong free cash flow generation. Key risks include gold price volatility and operational execution. Analyst consensus favors Buy with $37.20 price target representing 35% upside potential from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Kinross Gold Corporation
Kinross Gold is a Canada-based senior gold producer, producing roughly 2.4 million gold equivalent ounces in 2020. The company had 30 million ounces of proven and probable gold reserves and 59 million ounces of silver reserves at the end of 2020. It operates mines and focuses its greenfield and brownfield exploration in the Americas, West Africa, and Russia. The company has historically used acquisitions to fuel expansion into new regions and production growth.
Read more on KGC →
